Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 11Breast 6Head & Neck 4Tumor-Agnostic 2Thoracic 2Other 2Gynecologic 2Genitourinary 2Other hematologic neoplasm 1Dermatologic 1CNS 1

Conditions

Neoplasms 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Nutritional Status × Tumor-Agnostic × Clear all
NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

NCT04654637 2020-12-04

Multiple Interactive With Nutrition and Exercise Strategies in Frailty Cancer Patients

Tzu Chi University

Phase NA Unknown
128 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡